Financial targets and dividend policy
Optomed’s medium-term, from 2020 onwards, target is to deliver a double digit annual organic revenue growth.
In the long-term Optomed’s target is to deliver an average annual organic revenue growth above 20 percent.
Optomed’s target in the medium-term is to prioritise investments in the organisation to support growth and achieve an adjusted EBITDA margin above 30% in the long-term.
Optomed is in expansion phase and will therefore prioritise growth over dividends in coming years.